Streetbeat News

Regulatory

META

Four new studies have found that removing some algorithm functions on Meta Platforms' Facebook and Instagram had no measurable effects on people's political beliefs. The studies, which were conducted in collaboration with Meta, also found that political news consumption on the platforms was highly segregated by ideology. Despite these findings, researchers hope the studies will lead to more comprehensive work in the field. Meta spent $20 million on the research.

Portfolio Pulse from Anusuya Lahiri

July 28, 2023 | 1:55 pm

JAZZ

The U.S. Food and Drug Administration (FDA) has been criticized by Congress for its inaction on regulating CBD products. GOP representative Lisa McClain accused the FDA of asking for more resources before fulfilling its duties. The FDA had previously announced that it needs a new regulatory framework for hemp and CBD. The hearing followed the reintroduction of the Hemp Access and Consumer Safety Act by a bipartisan group of lawmakers, which aims to secure the FDA's regulation of hemp-derived CBD products. The FDA has approved Jazz Pharmaceuticals' Epidiolex, a CBD-based drug for treating severe forms of epilepsy.

Portfolio Pulse from Nina Zdinjak

July 28, 2023 | 1:53 pm

YOU

CLEAR has responded to a recent Bloomberg article, stating that it inaccurately portrays the company's security measures and its collaboration with the TSA in maintaining airport safety. CLEAR claims that despite providing reporters with factual information and on-the-record responses that contradict the article's content, Bloomberg chose to ignore these details.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 1:41 pm

EKSO

Ekso Bionics Holdings has filed for a stock shelf of up to $5 million, according to a SEC filing.

Portfolio Pulse from Happy Mohamed

July 28, 2023 | 1:32 pm

SPY

Senate Republican Leader McConnell has announced his intention to serve his full term as Leader in Senate, according to a spokesperson cited by Reuters.

Portfolio Pulse from Charles Gross

July 28, 2023 | 1:17 pm

LEXX

LEXXW

Lexaria Bioscience Corp. has incorporated a new wholly-owned subsidiary, Lexaria Nutraceutical Corp., to utilize its patented DehydraTECH Technology for creating consumer packaged goods and intermediate ingredients. The company also updated on its human oral nicotine study NIC-H22-1, expecting to release results within the next two weeks. The global market for the oral nicotine pouch category is growing rapidly, expected to reach $21.84 billion in 2027.

Portfolio Pulse from Happy Mohamed

July 28, 2023 | 1:11 pm

NTRA

Natera, Inc. (NASDAQ:NTRA) has completed enrollment for the phase III ALTAIR clinical trial, which is evaluating the utility of the Signatera molecular residual disease (MRD) test in patients with stage II-IV resectable colorectal cancer (CRC). The trial is part of the CIRCULATE-Japan adaptive trial platform. The company expects to share primary results from ALTAIR in mid-2024.

Portfolio Pulse from Happy Mohamed

July 28, 2023 | 1:01 pm

SPY

In an interview with the John Fredericks Show, former President Donald Trump stated that he will not halt his presidential campaign even if he is sentenced. The SPY ETF, which tracks the S&P 500, may be indirectly affected by this news due to its broad exposure to the US market.

Portfolio Pulse from Happy Mohamed

July 28, 2023 | 12:45 pm

SPY

The June report of the Personal Consumption Expenditure (PCE) price index shows a gradual decrease in price pressures across the economy. The Fed's preferred measure of underlying inflation fell to 4.1% YoY, slightly below economist projections of 4.2%. Concurrently, consumer spending increased 0.5% in June, exceeding estimates of a 0.4% gain. The SPDR S&P 500 ETF Trust (NYSE:SPY) achieved new yearly highs on Thursday, but fell 0.7% due to a surprising policy tweak by the Bank of Japan.

Portfolio Pulse from Piero Cingari

July 28, 2023 | 12:43 pm

DIS

NFLX

Disney (NYSE:DIS) plans to limit premium users of its Disney+ Hotstar streaming service in India to logging in from just four devices, following Netflix's (NASDAQ:NFLX) similar move. Currently, a Disney+ Hotstar premium account in India allows logins on up to 10 devices. The new restriction will also apply to its cheaper plan, limiting usage across two devices. Disney+ Hotstar led India’s streaming market from January 2022 to March 2023 with a 38% share of viewership.

Portfolio Pulse from Shomik Sen Bhattacharjee

July 28, 2023 | 12:43 pm